Praxis Precision Medicines, Inc. (PRAX) stock
PRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$305.19+0.13 (+0.04%)
Close on Nov 18, 2026Market cap $8.52BP/E –Yield –
Praxis Precision Medicines revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Praxis Precision Medicines's revenue for the twelve months ending Dec 31, 2025 was $0, down 100.0% year over year. For fiscal 2025 it was $0, down 100.0% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | -100.0% |
| FY2024 | Dec 31, 2024 | $8.55M | +249.5% |
| FY2023 | Dec 31, 2023 | $2.45M | – |
| FY2022 | Dec 31, 2022 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $0 | -100.0% |
| Q3 FY2025 | Sep 30, 2025 | $0 | -100.0% |
| Q2 FY2025 | Jun 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $0 | -100.0% |
| Q4 FY2024 | Dec 31, 2024 | $7.46M | +1349.1% |
| Q3 FY2024 | Sep 30, 2024 | $302.00K | -35.5% |
| Q2 FY2024 | Jun 30, 2024 | $357.00K | -54.3% |
| Q1 FY2024 | Mar 31, 2024 | $431.00K | -36.9% |
| Q4 FY2023 | Dec 31, 2023 | $515.00K | – |
| Q3 FY2023 | Sep 30, 2023 | $468.00K | – |
| Q2 FY2023 | Jun 30, 2023 | $781.00K | – |
| Q1 FY2023 | Mar 31, 2023 | $683.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
| Q3 FY2022 | Sep 30, 2022 | $0 | – |
| Q2 FY2022 | Jun 30, 2022 | $0 | – |
| Q1 FY2022 | Mar 31, 2022 | $0 | – |
See a number that looks wrong?